Core Viewpoint - Humana Inc. is expected to report strong first-quarter 2025 results, with earnings projected at $9.98 per share and revenues at $32.22 billion, indicating significant year-over-year growth [1][3]. Financial Performance - The first-quarter earnings estimate reflects a 38% year-over-year increase, while revenues are expected to grow by 9.8% [1]. - For the current year, Humana's revenue consensus estimate stands at $126.55 billion, representing an 8% year-over-year rise, and the EPS consensus is $16.36, indicating a growth of approximately 0.9% [3]. Earnings Expectations - Humana has consistently beaten earnings estimates in the past four quarters, with an average surprise of 15.4% [3]. - The company has a positive Earnings ESP of +0.57% and a Zacks Rank of 3 (Hold), suggesting a likelihood of an earnings beat this quarter [4]. Revenue Drivers - Revenue growth in Q1 is anticipated to be driven by higher premiums, with the consensus estimate for premiums at $30.7 billion, reflecting an 8.6% year-over-year increase [5]. - Revenues from Medicare stand-alone PDPs are expected to reach $1.7 billion, indicating a substantial year-over-year increase of 110.8% [5]. Membership Trends - Despite the expected revenue growth, total medical memberships are projected to decline by 3.8% year-over-year, primarily due to decreases in individual Medicare Advantage units and ASO commercial memberships [6]. Operating Expenses - Total operating expenses for the Insurance segment are estimated to grow by 7.6% year-over-year, attributed to higher operating costs [7].

Group 1: Market Overview - The market has experienced sharp volatility recently, but not all stocks have been negatively impacted, with UnitedHealth (UNH), Newmont (NEM), and Sprouts Farmers Market (SFM) showing positive gains [1][8]. Group 2: Newmont (NEM) - Newmont is one of the largest gold producers globally, with active mines in Nevada, Peru, Australia, and Ghana, benefiting from a surge in gold prices, resulting in a nearly 50% year-to-date performance increase [4]. - The average gold price per ounce reached $2,643, up from $2,004 in the same period last year, contributing to a record free cash flow of $1.6 billion [5]. - Analysts have raised their EPS expectations for Newmont, reflecting a bullish near-term outlook [7]. Group 3: UnitedHealth (UNH) - UnitedHealth provides a comprehensive range of health benefits, with its Optum segment leveraging data and technology to enhance care delivery and health outcomes [9]. - The company is expected to report a 5% year-over-year EPS growth on 11% higher sales, having exceeded EPS estimates in the last 20 quarterly releases [10][11]. - UnitedHealth's domestic operations provide a buffer against tariff concerns [11]. Group 4: Sprouts Farmers Market (SFM) - SFM has shown strong performance, exceeding consensus EPS and sales expectations for the last ten quarters, with a stock increase of nearly 160% over the past year [12]. - The company reported $2.0 billion in sales, reflecting a 17% year-over-year growth, indicating strong demand [14]. - SFM holds a Zacks Rank 1 (Strong Buy), with a notably bullish EPS outlook [15]. Group 5: Conclusion - Despite ongoing market volatility and tariff headlines, UnitedHealth, Newmont, and Sprouts Farmers Market have all demonstrated upward momentum and possess bullish near-term EPS outlooks [16].